About GPLIFE Healthcare
ABOUT GPLIFE HEALTHCARE

Pioneering Botanical Science & Global Healthspan Innovation

Two decades of scientific excellence, visionary leadership, and active causality discovery — bridging nature's phytochemistry with modern clinical medicine.

VISION • MISSION • CORE VALUES

Official website content — Gplife About Us

VISION

First, Do No Harm

  • Replace All Unscientific Drugs with Botanical Active Causality target dosage form
  • Become Scientifically Proven Adjuvant Treatment for every Phytochemistry based dosage we invent
MISSION

Make Healthcare Noble Again

Solve Chronic Diseases by cell regeneration active causality target and Make Healthcare Noble Again.
CORE VALUES

Core Values

  • INNOVATION: We are expertise in synergistic phytochemical active causality target molecules derived from botanical ingredients to solve chronic disease.
  • PURITY: Our Products are derived from pure botanical isolated standardized form, Compliance with Quality, Toxicity and Stability guideline.
  • EXCELLENCE: Our Artificial intelligence model, process patentability and measurable outcomes by clinical research are key USP of our research whatweinventtomakehealthcare nobleagain.
Dr. Chetan Savaliya - Founder & CMD, Gplife Healthcare
Founder & CMD
$101M XPRIZE Healthspan Global Finalist (USA)
Executive Profile

Dr. Chetan Savaliya

Chairman & Managing Director (CMD) & Founder | Gplife Healthcare

Dr. Chetan Savaliya, the Visionary entrepreneur behind one of India's fastest-emerging science-driven preventive healthcare organizations. As the architect of Gplife's long-term business strategy, he has transformed the company from an entrepreneurial vision into an integrated healthcare enterprise focused on longevity, Healthspan, personalized wellness, artificial intelligence, and evidence-based botanical healthcare.

With a strong entrepreneurial mindset and long-term value creation strategy, Dr. Savaliya has built Gplife around sustainable innovation, scalable business models, intellectual property development, strategic partnerships, and customer-centric healthcare solutions. His leadership has enabled Gplife to evolve beyond a conventional supplement company into a technology-enabled preventive healthcare platform with significant national and international growth potential.

International Recognition & XPRIZE Achievement

Under his leadership, Gplife Healthcare has earned international recognition as a Global Finalist in the prestigious $101 Million XPRIZE Healthspan Competition (USA), reinforcing the company's position among the world's leading organizations working toward healthier ageing and preventive healthcare innovation.

Root-Cause Pharmacology
25+ Process Patents
10,000 Wellness Centres Vision

Strategic Pillars of Leadership & Value Creation

A comprehensive framework guiding GPLIFE's innovation, enterprise growth, and global healthspan impact.

Pillar I

Entrepreneurial Leadership & Vision

  • Founder-Led Enterprise: Dr. Chetan Savaliya founded Gplife Healthcare with the vision of creating a globally respected preventive healthcare company built on scientific credibility, innovation, quality, and long-term value creation.
  • Building a Scalable Organization: He has successfully developed an integrated business ecosystem spanning research, manufacturing, artificial intelligence, digital healthcare, clinical validation, wellness services, and national distribution.
  • Strategic Business Leadership: His leadership focuses on creating sustainable competitive advantages through innovation, operational excellence, brand differentiation, and disciplined execution.
  • Purpose-Driven Growth: Rather than competing solely on products, Dr. Savaliya has positioned GPLIFE as a comprehensive healthcare platform addressing preventive healthcare, longevity, metabolic wellness, and healthy ageing.
Pillar II

Business Growth & Market Expansion

Dr. Savaliya has led the company's rapid expansion through a structured growth strategy centered on innovation, distribution, and scalable healthcare delivery. Key strategic initiatives include:

  • Building a rapidly expanding nationwide preventive healthcare network through Gplife Wellness Centres.
  • Developing AI-enabled personalized healthcare platforms that integrate diagnostics, biomarker analysis, and wellness recommendations.
  • Establishing strategic collaborations with healthcare professionals, wellness consultants, hospitals, corporate organizations, and institutional partners.
  • Driving expansion into national and international markets through scalable franchise, licensing, and strategic partnership models.
  • Creating multiple revenue streams across preventive healthcare, clinical wellness, digital health, nutraceuticals, and personalized healthcare services.
Pillar III

Enterprise Value Creation

Dr. Savaliya has positioned Gplife as a high-value healthcare enterprise by focusing on long-term asset creation rather than short-term commercial growth. His value creation strategy includes:

  • Building a diversified intellectual property and proprietary technology portfolio.
  • Investing in clinical research, evidence generation, and scientific validation to strengthen market credibility.
  • Developing AI-driven healthcare technologies with scalable commercial applications.
  • Creating a differentiated healthcare brand positioned within the rapidly growing global longevity and preventive healthcare sector.
  • Building strong organizational capabilities capable of supporting future strategic partnerships, institutional investments, licensing opportunities, and international expansion.
Pillar IV

Commercial Excellence & Brand Leadership

Dr. Savaliya has been instrumental in building Gplife's commercial foundation through customer-focused business strategies. Major areas of focus include:

  • Brand positioning in the premium preventive healthcare and longevity segment.
  • Development of scalable sales and distribution networks across multi-channel touchpoints.
  • Expansion through healthcare professionals, wellness practitioners, and strategic channel partners.
  • Digital transformation of customer engagement and personalized wellness management.
  • Establishing a trusted reputation through quality, transparency, compliance, and measurable health outcomes.
“Healthcare is entering a new era where value will be created by prevention rather than treatment. Our mission is to build a globally respected healthcare organization that combines innovation, technology, scientific excellence, and scalable business models to improve quality of life while creating long-term value for patients, partners, investors, and society.”

Dr. Chetan Savaliya

Chairman & Managing Director & Founder, Gplife Healthcare

Dr. Shridhar Pandya - Co-founder, Director & Chief Scientific Officer
Co-founder, Director & CSO
$101M XPRIZE Healthspan Global Finalist (USA)
Scientific Leadership

Dr. Shridhar Pandya

Co-founder, Director & Chief Scientific Officer | Gplife Healthcare

Dr. Shridhar Pandya is the visionary founder and the driving force behind Gplife Healthcare. With over 21 years of deep scientific research in botanical and Phyto-pharma sciences, Dr. Pandya has transformed the landscape of longevity and anti-aging through a unique integration of pharmaceutical technology and Artificial Intelligence.

Under his leadership, Gplife Healthcare has emerged as a global finalist in the $101M XPRIZE Healthspan, ranking among the top innovators worldwide for aging reversal and Healthspan enhancement.

Pioneering Clean Science & AI-Driven Wellness

Pioneered Excipient-less active drug delivery, Nano-phytochemical dosages, and AI-driven causality mapping across 450+ botanical molecules to target root causes of chronic disease and extend healthy human healthspan.

21+ Years Research
60+ Scientists & 100+ Scholars
250+ Biomarker Mapping
100% Active Excipient-less

Scientific Heritage & Phyto-Pharma Innovations

Pioneered by Dr. Shridhar Pandya — Bridging ancient botanical wisdom with modern AI intelligence, cellular validation, and root-cause pharmacology.

Pillar I

Leadership & Scientific Heritage

  • Founder-Led Innovation: Dr. Shridhar Pandya leads a multidisciplinary scientific ecosystem comprising 60+ scientists, 100+ research scholars and AI experts, driving long-term innovation in novel Phyto research and advanced manufacturing technologies. Under his leadership, Gplife prioritizes evidence-based scientific discovery, translational research, and next-generation botanical therapeutics over conventional generic manufacturing.
  • Two Decades of Research: His work, rooted in botanical science since 2006, is validated through peer-reviewed publications and IVIVC & Clinical research.
  • Cellular Validation: He pioneered research protocols that validate the efficacy and regenerative properties of formulations at the cell-line level.
Pillar II

Pioneer of AI-Driven Wellness

Dr. Pandya has bridged the gap between traditional medicine and modern technology by developing:

  • AI-Driven Phyto-Causality Technology: A proprietary synergy algorithm designed to create precise, root-cause-based formulations.
  • Gplife Wellness Intelligence Platform: A comprehensive digital ecosystem for health diagnosis and tracking.
  • 250+ Biomarker Mapping: A diagnostic approach that monitors over 250 biomarkers to provide measurable health improvements.
Pillar III

Technical Innovations in Phyto-Pharma

Dr. Pandya’s commitment to “Clean Science” has led to several industry-first achievements:

  • Excipient-less Technology: The development of 100% active-ingredient formulations (tablets and capsules) without harmful binders, fillers, or chemical additives.
  • Nano-Phytochemical Dosages: Utilizing nanotechnology to ensure high bioavailability and rapid absorption.
  • Synergistic Formulations: Mapping over 450+ phytochemicals to ensure maximum therapeutic impact through precise botanical combinations.
Pillar IV

Global Impact & Clinical Excellence

  • Biological Age Reversal: His research focuses on the molecular mechanisms of cellular aging, aiming to slow or reverse the biological clock.
  • Multi-Organ Targeting: Formulations designed to simultaneously address the interconnected systems of the Brain, Heart, Liver, Kidney, and Gut.
  • Clinical Safety: All products are manufactured in GMP & FSSAI certified facilities, following ICH-Guideline stability testing and NABL-approved laboratory standards.
  • Supportive Therapy: Dr. Pandya’s formulations are trusted by over 100+ health practitioners as safe add-on therapies that work alongside conventional medicine.
“Our goal is not just to manage symptoms, but to manage blood biomarkers homeostasis and enhance the human Healthspan. By combining the intelligence of nature with the precision of AI, we are making aging a manageable condition rather than an inevitable decline.”

Dr. Shridhar Pandya

Co-founder, Director & Chief Scientific Officer, Gplife Healthcare

Advancing Longevity, Healthspan & Precision Preventive Healthcare

An integrated ecosystem combining botanical science, clinical research, cellular biology, and AI-enabled health intelligence to deliver evidence-based wellness solutions across the human healthspan.

Diabetes & Metabolic Wellness

Core focus on Diabetes management, healthy body weight optimization, excess body fat reduction, lean muscle composition improvement, blood glucose homeostasis, metabolic flexibility, liver wellness (including fatty liver management), lipid profile balance, thyroid support, and healthy blood pressure regulation.

Blood Glucose Metabolic Flexibility Fatty Liver Care Lipid Balance

Cellular Health & Healthy Ageing

Optimal health begins at the cellular level. Supporting cellular regeneration, age-related physiological wellness, and targeted nutritional interventions addressing common micronutrient deficiencies including Vitamin B12, Vitamin D3, calcium, magnesium, iron, and trace minerals to sustain cellular energy, bone strength, and immune resilience.

Cellular Regeneration Vitamin B12 & D3 Bioavailable Minerals Mitochondrial Vitality

Brain Health & Cognitive Wellness

Comprehensive programs addressing memory enhancement, mental clarity, concentration, cognitive performance, alertness, stress resilience, anxiety management, emotional wellbeing, healthy sleep cycle optimization, and chronic migraine support through neuroprotective phytochemistry.

Memory Enhancement Stress Resilience Sleep Optimization Migraine Support

Gastrointestinal & Gut Microbiome

Promoting gut microbiome equilibrium, healthy digestion, efficient nutrient absorption, and reliable relief from common gastrointestinal discomforts including gas, acidity, bloating, indigestion, and gut-barrier permeability challenges.

Microbiome Balance Nutrient Absorption Acidity & Gas Relief Digestive Comfort

Immune Resilience & Respiratory Care

Strengthening immunological response and respiratory function, offering targeted nutritional support for seasonal coughs and colds, environmental allergy management, pulmonary performance, lung health, and recovery support for individuals affected by smoking or tobacco exposure.

Immune Defense Lung Health Allergy Management Tobacco Defense

Specialized Wellness & Musculoskeletal

Dedicated solutions covering aesthetic wellness (skin radiance, collagen synthesis, acne, scalp health, hair growth), women's hormonal balance & PMOS support, men's prostate & reproductive vitality, joint health, arthritis management, mobility, pain reduction, vision wellness, and supportive care for long-term chronic conditions.

Skin & Hair Collagen Women's Hormonal Care Men's Health & Prostate Joint & Mobility

Evidence-Based Integration: Gplife Healthcare integrates advanced phytopharmaceutical research, clinical studies, cellular validation, artificial intelligence, systems biology, precision nutrition, and personalized health analytics to develop next-generation preventive healthcare solutions. By combining traditional botanical knowledge with modern biomedical science and digital technologies, Gplife aims to empower individuals to proactively manage their health, reduce future disease risk, and improve overall Healthspan worldwide.

SCIENTIFIC TEAM OF GPLIFE HEALTHCARE PVT LTD - INDIA

A 49-member multidisciplinary scientific ecosystem comprising esteemed clinicians, pharmacologists, AI researchers, and healthcare professionals across India, Germany, UAE, Russia, USA, Canada, UK, France & Australia.

01. Dr. Shridhar Pandya
India
02. Dr. Dheeraj Nagore
India
03. Dr. Shital Rede
India
04. Dr. Gayatri Ganu
India
05. Vaishnavi Ghodke
India
06. Shivangi Dave
India
07. Prerana Patil
India
08. Dr. Megha Lokhande
India
09. Dr. Sakshi wattamwar
India
10. Dr. Kushal Rathod
India
11. Dr. Sonal Sharma
India
12. Dr. Juergen Heschler
Germany
13. Dr. Issa Salim
UAE
14. Dr. T. Yunus Pasha
India
15. Dr. Jayesh Shah
India
16. Dr. Smita Bonde
India
17. Dr. Vaishali undale
India
18. Dr. Devang Gandhi
India
19. Dr. Vaishnavi Patil
India
20. Dr. Tanuja Panchbhai
India
21. Dr. Amol Gothwad
India
22. Dr. Anu Choudhary
India
23. Dr. Tiumina Olga
Russia
24. Dr. Shashikant Bhandari
India
25. Dr. Hemang Joshi
India
26. Dr. Vandna Sharma
India
27. Dr. Pranil Surve
India
28. Dr. Sweety Chaudhary
India
29. Chirag Vidja
India
30. Shanti bhai Vidja
India
31. Axay Vidja
India
32. Arti Patel
India
33. Hitesh Gondaliya
India
34. Falguni Pandya
India
35. Pragati Reshamwala
India
36. Shivani Mehta
Canada
37. Biren Shah
Paris
38. Arvind Gajera
India
39. Harsh Shah
USA
40. Nency Raja
India
41. Ruchi Upadhyay
India
42. Ankit Khushwah
India
43. Mansi Vaghela
London
44. Isha Vyas
India
45. Keval Pathak
Canada
46. Suhrud Pathak
USA
47. Urvashi Sangule
Germany
48. Rupal Panchal
Australia
49. Chintal Raval
India

21-Year Journey • From Formulation Science to Global Longevity

A chronological timeline tracing two decades of breakthrough research, active causality pharmacology, patent portfolios, clinical trials, and global healthspan recognition (2006–2026).

2006–2008

Building the Scientific Foundation

GPLIFE commenced its journey by establishing deep expertise in pharmaceutical formulation science and advanced drug delivery technologies. Early research focused on improving therapeutic performance through innovative formulation approaches, laying the scientific foundation for future translational research.

Core Research Areas

  • Taste masking technologies
  • Controlled and modified drug release
  • Advanced coating systems
  • Solubility enhancement
  • Micromeritics optimization
  • Photostability studies
  • Natural vs. synthetic excipient evaluation
Outcome

Established strong capabilities in pharmaceutical formulation science and delivery system engineering.

2008–2010

Advanced Drug Delivery & Analytical Excellence

GPLIFE expanded into sophisticated drug delivery platforms while building state-of-the-art analytical capabilities for botanical and pharmaceutical research.

Scientific Advancements

  • Orally Disintegrating Tablets (ODTs)
  • Gastro-retentive systems
  • Sustained-release formulations
  • Bilayer tablet technologies
  • Ion-exchange delivery systems
  • Statistical Quality-by-Design optimization

Analytical Infrastructure

  • HPLC
  • FTIR
  • DSC
  • XRD
  • UV Spectroscopy
Outcome

Developed a robust analytical platform capable of phytochemical characterization and active compound identification.

2010–2012

AI-Driven Botanical Science Begins

Recognizing the potential of botanical therapeutics, GPLIFE transitioned toward AI-assisted phytochemical research for chronic metabolic disorders.

Key Breakthroughs

Outcome

Created the scientific framework for AI-enabled precision botanical therapeutics.

2012–2014

Expansion into Multi-Disease Therapeutics

GPLIFE broadened its botanical research platform to address multiple chronic diseases using standardized scientific methodologies.

Research Portfolio

  • Diabetes
  • Arthritis
  • Obesity
  • Hypercholesterolemia
  • Kidney Stone
  • Digestive Health
  • Respiratory Wellness
  • Proctology (Piles)

Platform Development

  • Stability studies
  • Heavy metal profiling
  • Microbial safety validation
  • Botanical standardization
  • Statistical optimization
Outcome

Established a scalable botanical R&D platform capable of supporting multiple therapeutic indications.

2014–2016

Proprietary Botanical Delivery Technologies

Research shifted toward improving botanical bioavailability, stability, and clinical performance through proprietary delivery technologies.

Technology Innovations

  • Self-Micro Emulsifying Drug Delivery Systems (SMEDDS)
  • Freeze-drying (Lyophilization)
  • Vacuum drying technologies
  • Natural super-disintegrants
  • Natural preservative systems

Advanced Characterization

  • HPLC
  • HPTLC
  • GC
  • FTIR
  • DSC
  • XRD
Outcome

Successfully commercialized multiple evidence-based botanical products across therapeutic categories.

2016–2018

Breakthrough Formulation Innovation

GPLIFE developed novel technologies that differentiated its scientific platform.

Major Innovations

  • India's first Excipient-Free Tablet Technology
  • AI-assisted formulation optimization
  • IVIVC (In Vitro–In Vivo Correlation) platform
  • Advanced aqueous coating technology
  • Regulatory intelligence systems
  • Expansion into nutraceuticals and cosmeceuticals
Outcome

Transitioned from formulation expertise to proprietary technology development and intellectual property creation.

2019–2021

Transformation into an AI-Driven Healthcare Company

GPLIFE Healthcare Pvt. Ltd. was established, integrating artificial intelligence, clinical science, and botanical therapeutics into a unified research ecosystem.

Scientific Milestones

  • AI-powered IVIVC models
  • Synergistic Phyto-Intelligence Platform
  • Evaluation of 450+ botanical ingredients
  • Multiple diabetes clinical studies
  • Comprehensive toxicology research
  • Portfolio expansion to 20+ evidence-based products

COVID-19 Research

During the pandemic, GPLIFE developed botanical interventions supported by:

  • Animal studies
  • Phase III clinical research
  • Scientific publications & Multiple patent filings
Outcome

Successfully evolved into an integrated AI-powered life sciences company.

2022

Transition to Regenerative Medicine

GPLIFE expanded beyond disease management into regenerative biology and tissue restoration.

Research Programs

  • Pancreatic beta-cell regeneration
  • Cartilage regeneration
  • Synovial fluid regeneration
  • Stem-cell supportive botanical therapeutics
  • AI-powered clinical software platform

Achievements

  • Eight completed clinical trials
  • 50+ commercial products
  • 150+ products in development
  • Significant expansion of intellectual property
Outcome

Positioned regenerative medicine as a strategic pillar of the company's innovation platform.

2023–2024

Entering the Global Longevity Ecosystem

GPLIFE strategically entered longevity science, focusing on extending healthspan through precision, AI, and botanical therapeutics.

Research Focus

  • Healthy aging
  • Longevity
  • Cognitive resilience
  • Muscle restoration
  • Chronic inflammation
  • Immunomodulation

Global Recognition

  • Multiple international patent filings
  • Expanded scientific publications
  • Proof-of-concept accepted into the XPRIZE Healthspan competition
  • Selected among the World's Top 200 Longevity Research Teams
Outcome

Established GPLIFE as an emerging global innovator in longevity science.

2025

International Validation

GPLIFE received international recognition for its pioneering work in healthy longevity and biological age reversal.

Major Achievements

  • Top 100 Team in XPRIZE Healthspan
  • Milestone 1 Recognition
  • 25+ Patent Portfolio
  • 10 Human Clinical Trials
  • 250+ Scientific Publications
  • Four Cell Regeneration Programs
  • Launch of GPLIFE Wellness Hub

Strategic Vision

A scalable global network of 10,000 AI-enabled Wellness & Longevity Centers.

Outcome

Validated GPLIFE's scientific platform on the international stage.

2026

Global Top 10 in XPRIZE Healthspan

GPLIFE achieved its most significant scientific milestone by advancing into the Global Top 10 Finalists of the XPRIZE Healthspan competition, positioning the company among the world's leading innovators in healthy longevity and biological age reversal.

AI-Powered Precision Health Platform

GPLIFE launched its integrated digital longevity ecosystem featuring:

  • Organ Health Assessment
  • Biomarker Intelligence
  • Symptom Analytics
  • Biological Age Assessment
  • Personalized Nutraceutical Recommendations
Platform Availability & Expansion

The platform became available across both iOS and Android, while the GPLIFE Wellness Hub franchise network entered national expansion.

Scientific Evolution (2006–2026)

01

Pharmaceutical Science

02

Drug Delivery Technologies

03

AI-Driven Botanical Therapeutics

04

Clinical Validation

05

Regenerative Medicine

06

Longevity Science

07

Precision AI Healthcare

08

Global Healthspan Innovation

The Result

20 Years of Scientific Innovation

25+ Patent Portfolio
250+ Scientific Publications
32 Human Clinical Trials 450+ Botanical Ingredients Screened
150+ Research Products Developed
Multiple Regenerative Medicine Programs
AI-Powered Precision Health Platform
Global Top 10 Finalist — XPRIZE Healthspan

Vision

“To become the world's leading AI-powered longevity science company — integrating botanical intelligence, regenerative medicine, clinical evidence, and digital health to extend healthy human lifespan.”